Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Capricor Therapeutics Ownership Summary


Capricor Therapeutics is owned by 25.29% institutional investors, 16.73% insiders, and 57.98% retail investors. Blackrock is the largest institutional shareholder, holding 5.19% of CAPR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.49% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCapricor Therapeutics25.29%16.73%57.98%
SectorHealthcare Stocks 45.73%8.14%46.12%
IndustryBiotech Stocks 43.86%7.98%48.16%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock1.63M5.19%$7.77M
Vanguard group1.55M4.94%$7.39M
Geode capital management641.57K2.05%$3.06M
Millennium management479.51K1.53%$2.29M
State street401.02K1.28%$1.91M
Advisor group162.30K0.52%$774.17K
Caption management130.50K0.42%$622.49K
Northern trust129.61K0.41%$618.25K
Goldman sachs group82.70K0.26%$394.46K
Bank of new york mellon79.78K0.25%$380.56K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Adar1 capital management20.40K0.02%$97.31K
Activest wealth management10.00K0.02%$47.70K
Coastal bridge advisors10.89K0.01%$51.96K
Main street financial solutions27.50K0.01%$131.18K
Caption management130.50K0.01%$622.49K
Oppenheimer54.65K0.00%$260.66K
Householder group estate & retirement specialist1.50K0.00%$7.00K
Advisor group162.30K0.00%$774.17K
Millennium management479.51K0.00%$2.29M
Tower research capital llc (trc)9.52K0.00%$45.43K

Top Buyers

HolderShares% AssetsChange
Blackrock1.63M0.00%1.25M
Geode capital management641.57K0.00%313.10K
State street401.02K0.00%284.30K
Millennium management479.51K0.00%186.47K
Vanguard group1.55M0.00%183.04K

Top Sellers

HolderShares% AssetsChange
Renaissance---137.50K
Goldman sachs group82.70K0.00%-130.47K
Arrowstreet capital, limited partnership---101.54K
Marshall wace, llp---89.31K
Man group---84.65K

New Positions

HolderShares% AssetsChangeValue
Caption management130.50K0.01%130.50K$622.49K
Oppenheimer54.65K0.00%54.65K$260.66K
Nuveen asset management34.32K-34.32K$163.71K
Rhumbline advisers30.89K0.00%30.89K$147.32K
New york state common retirement fund21.60K0.00%21.60K$103.00K

Sold Out

HolderChange
Fmr-1.00
Federated hermes-68.00
Yhb investment advisors-150.00
Macquarie group-941.00
Lazard asset management-2.69K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20249438.24%8,369,32730.24%256.02%5633.33%11-26.67%
Jun 30, 2024687.94%6,426,23433.35%208.30%42-1566.67%
Mar 31, 20246357.50%4,818,91920.83%156.59%4290.91%912.50%
Dec 31, 2023408.11%3,988,123-27.56%153.27%2283.33%8-27.27%
Sep 30, 2023372.78%5,505,593112.21%2120.58%12-25.00%1157.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.13M2.49%260.50K
iShares Russell 2000 ETF665.60K1.47%-1.50K
Vanguard Institutional Extnd Mkt Idx Tr455.53K1.00%-23.41K
Fidelity Small Cap Index263.18K0.58%-6.16K
iShares Russell 2000 Growth ETF198.75K0.44%-
Fidelity Extended Market Index175.44K0.39%-15.84K
State St Russell Sm/Mid Cp® Indx NL Cl C169.29K0.37%31.50K
Vanguard Russell 2000 ETF115.48K0.25%-738.00
BlackRock Extended Equity Market K71.61K0.20%-30.00
State St Russell Sm Cap® Indx SL Cl I88.00K0.19%-30.20K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 20, 2024Nippon Shinyaku Co Ltd-Buy$15.00M
Oct 12, 2023Musket David B-Buy$1.13K
Oct 10, 2023COLLIER EARL M JR-Buy$28.30K
Oct 09, 2023Musket David B-Buy$14.33K
Oct 06, 2023Auwaerter Paul Gisbert-Buy$14.20K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q31-
2024 Q2--
2024 Q1--
2023 Q45-

CAPR Ownership FAQ


Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 25.29%, followed by 16.73% insiders and 57.98% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 43.86%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock (1.63M shares, 5.19%), Vanguard group (1.55M shares, 4.94%), and Geode capital management (641.57K shares, 2.05%). Together, they hold 12.18% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Adar1 capital management is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 20.4K Capricor Therapeutics shares, valued at 97.31K$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Capricor Therapeutics shares, with 2.49% of its total shares outstanding invested in 1.13M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools